报价延迟最少15分钟:2025/07/19 21:08 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.15 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.30/-0.64
|
|
企业价值
1.61B
|
| 资产负债 |
|
每股账面净值
5.74
|
| 现金流量 |
|
现金流量率
0.04
|
| 损益表 |
|
收益
610.79M
|
|
每股收益
4.80
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/07/19 21:08 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China). |
